Nipradilol, a new β-adrenergic blocker, reduces left ventricular remodeling following myocardial infarction in spontaneously hypertensive rats-Reference-Cited by-同舟云学术

Nipradilol, a new β-adrenergic blocker, reduces left ventricular remodeling following myocardial infarction in spontaneously hypertensive rats

Published:1997-01 Issue:1 Volume:12 Page:19-26
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Sonoki Hiroyuki,Nakamura Masaki,Takeshita Akira

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF01747498.pdf

Reference39 articles.

1. Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E (1991) Progressive ventricular remodeling in rats with myocardial infarction. Am J Physiol 261:H1406-H1414

2. Vaughan DE, Pfeffer MA (1994) Post-myocardial infarction ventricular remodeling: Animal and human studies. Cardiovasc Drug Ther 8:453–460

3. White HD, Norris RM, Brown MA, Brandt PWT, Whitlock RHL, Wild CJ (1987) Left ventricular endsystolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76:44–51

4. Hammermeister KE, DeRouten TA, Dodge HT (1987) Variables predictive of survival in patients with coronary disease: selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluation. Circulation 59:421–430

5. Pfeffer JM, Pfeffer MA, Braunwald E (1985) Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 57:84–95

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neural mechanism of angiotensin-converting enzyme inhibitors in improving heart rate variability and sleep disturbance after myocardial infarction;Sleep Medicine;2018-08

2. Multifunctional compounds containing organic nitrates, prototypes of hybrid medicaments;Russian Chemical Reviews;2009-05-31

3. Pharmacodynamic Hybrids Coupling Established Cardiovascular Mechanisms of Action with Additional Nitric Oxide Releasing Properties;Current Pharmaceutical Design;2009-02-01

4. NO-Releasing Hybrids of Cardiovascular Drugs;Current Medicinal Chemistry;2006-03-01

5. Direct measurement of nipradilol-derived nitric oxide in the vascular wall of canine femoral arteries;Heart and Vessels;2005-07-15